SEC Form 4 · accession 0001349929-16-000105
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Pappajohn
Director · 10% Owner
Period of report
Aug 16, 2016
Accepted (ET)
Aug 17, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Aug 16, 2016 | P | 45,000 | $2.2934 | A | 2,287,109 | D |
Table II — derivative securities
No Table II lines on this filing.